1. Home
  2. CCCC vs BGH Comparison

CCCC vs BGH Comparison

Compare CCCC & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • BGH
  • Stock Information
  • Founded
  • CCCC 2015
  • BGH 2012
  • Country
  • CCCC United States
  • BGH United States
  • Employees
  • CCCC N/A
  • BGH N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • BGH Investment Managers
  • Sector
  • CCCC Health Care
  • BGH Finance
  • Exchange
  • CCCC Nasdaq
  • BGH Nasdaq
  • Market Cap
  • CCCC 304.8M
  • BGH 289.9M
  • IPO Year
  • CCCC 2020
  • BGH N/A
  • Fundamental
  • Price
  • CCCC $6.25
  • BGH $14.91
  • Analyst Decision
  • CCCC Buy
  • BGH
  • Analyst Count
  • CCCC 7
  • BGH 0
  • Target Price
  • CCCC $8.71
  • BGH N/A
  • AVG Volume (30 Days)
  • CCCC 2.5M
  • BGH 61.5K
  • Earning Date
  • CCCC 08-06-2024
  • BGH 01-01-0001
  • Dividend Yield
  • CCCC N/A
  • BGH 10.06%
  • EPS Growth
  • CCCC N/A
  • BGH N/A
  • EPS
  • CCCC N/A
  • BGH N/A
  • Revenue
  • CCCC $20,036,000.00
  • BGH N/A
  • Revenue This Year
  • CCCC $26.24
  • BGH N/A
  • Revenue Next Year
  • CCCC N/A
  • BGH N/A
  • P/E Ratio
  • CCCC N/A
  • BGH N/A
  • Revenue Growth
  • CCCC N/A
  • BGH N/A
  • 52 Week Low
  • CCCC $1.06
  • BGH $11.92
  • 52 Week High
  • CCCC $11.88
  • BGH $14.50
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 60.64
  • BGH 60.89
  • Support Level
  • CCCC $4.36
  • BGH $14.90
  • Resistance Level
  • CCCC $7.66
  • BGH $15.27
  • Average True Range (ATR)
  • CCCC 0.56
  • BGH 0.15
  • MACD
  • CCCC 0.27
  • BGH 0.02
  • Stochastic Oscillator
  • CCCC 57.34
  • BGH 58.62

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.

Share on Social Networks: